Search research articles
Contact Us
Filters
Showing results (1181-1190 of 1,268) with videos related to
Page
of 127
Sort By:
The Journal of Biological Chemistry
|
August 12, 2000
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis
R A Copeland, J Marcinkeviciene, T S Haque, et al.
Journal of Neuroscience Methods
|
March 24, 2015
Investigating the psychosocial determinants of child health in Africa: The Drakenstein Child Health Study
D J Stein, N Koen, K A Donald, et al.
The Primary Care Companion for CNS Disorders
|
March 18, 2022
Phenotyping of Review-of-Systems Responses to Differentiate Functional Seizures From Epilepsy
Wesley T Kerr, Corinne H Allas, Siddhika S Sreenivasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
Howard M Stern, Humphrey Gardner, Tomasz Burzykowski, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
May 8, 2024
Prospective 2-Year Course and Predictors of Outcome in Avoidant/Restrictive Food Intake Disorder
P Evelyna Kambanis, Nassim Tabri, Iman McPherson, et al.
Nature
|
June 1, 2000
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi, D C Blood, G del Toro, et al.
Genes and Immunity
|
June 19, 2002
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
M A Hofmann, S Drury, B I Hudson, et al.
The Journal of Cell Biology
|
October 8, 2008
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
Michael Degtyarev, Ann De Mazière, Christine Orr, et al.
Breast Cancer Research and Treatment
|
February 20, 2013
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
Edith A Perez, Michael F Press, Amylou C Dueck, et al.
The American Journal of Pathology
|
March 26, 2003
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
Thoralf M Wendt, Nozomu Tanji, Jiancheng Guo, et al.
Page
of 127
Search research articles
Search
Showing results (1181-1190 of 1,268) with videos related to
Sort By:
Page
of 127
The Journal of Biological Chemistry
|
August 12, 2000
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis
R A Copeland, J Marcinkeviciene, T S Haque, et al.
Journal of Neuroscience Methods
|
March 24, 2015
Investigating the psychosocial determinants of child health in Africa: The Drakenstein Child Health Study
D J Stein, N Koen, K A Donald, et al.
The Primary Care Companion for CNS Disorders
|
March 18, 2022
Phenotyping of Review-of-Systems Responses to Differentiate Functional Seizures From Epilepsy
Wesley T Kerr, Corinne H Allas, Siddhika S Sreenivasan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2015
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
Howard M Stern, Humphrey Gardner, Tomasz Burzykowski, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
May 8, 2024
Prospective 2-Year Course and Predictors of Outcome in Avoidant/Restrictive Food Intake Disorder
P Evelyna Kambanis, Nassim Tabri, Iman McPherson, et al.
Nature
|
June 1, 2000
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi, D C Blood, G del Toro, et al.
Genes and Immunity
|
June 19, 2002
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response
M A Hofmann, S Drury, B I Hudson, et al.
The Journal of Cell Biology
|
October 8, 2008
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
Michael Degtyarev, Ann De Mazière, Christine Orr, et al.
Breast Cancer Research and Treatment
|
February 20, 2013
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
Edith A Perez, Michael F Press, Amylou C Dueck, et al.
The American Journal of Pathology
|
March 26, 2003
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
Thoralf M Wendt, Nozomu Tanji, Jiancheng Guo, et al.
Page
of 127